← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-010 | 71170-010-10 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-012 | 73198-012-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8240 | 71266-8240-5 | Phenylephrine Hydrochloride; Ketorolac Tromethamine; Tropicamide; Cyclopentolate Hydrochloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0404 | 72196-0404-1 | Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1201 | 1201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Niacinamide; Dexpanthenol; Pyridoxine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-016 | 72055-016-01 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1201 | 1201 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0001 | 26436-0001-1 | Sildenafil Citrate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1202 | 1202 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6055 | 71285-6055-1 | Diltiazem 125mg added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6092 | 72196-6092-1 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-025 | 73198-025-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8221 | 71266-8221-1 | Phenylephrine Hydrochloride; Ketorolac Tromethamine; Tropicamide; Cyclopentolate Hydrochloride; Proparacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1202 | 1202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Proline; Lysine Hydrochloride; Arginine Hydrochloride; Citrulline | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-129 | 73702-129-15 | Rocuronium | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-014 | 72055-014-01 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1202 | 1202 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-101 | 73198-101-30 | Sodium Bicarbonate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1203 | 1203 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9032 | 71266-9032-1 | Phenylephrine HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1486 | 5446-1486-01 | Glycerin | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1203 | 1203 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-1 | Neostigmine Methylsulfate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1203 | 1203 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8603 | 71266-8603-1 | Moxifloxacin Hydrochloride | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-010 | 71506-010-58 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-026 | 71506-026-51 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-025 | 73198-025-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1203 | 1203 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-515 | 81375-515-01 | Phenylephrine Hydrochloride; Lidocaine | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-004 | 71449-004-15 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1203 | 1203 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1204 | 1204 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate 1mg added to 100mL NS Bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1204 | 1204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin; Epinephrine; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1204 | 1204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-976 | 70731-976-30 | Niacinamide; Riboflavin 5'-Phosphate Sodium; Dexpanthenol; Thiamine Hydrochloride; Pyridoxine Hydrochloride | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6057 | 71285-6057-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8602 | 71266-8602-1 | Moxifloxacin Hydrochloride | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1204 | 1204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1204 | 1204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6360 | 71266-6360-1 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1204 | 1204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Proparacaine Hydrochloride; Povidone-Iodine | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-004 | 71449-004-11 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1204 | 1204 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-950 | 71170-950-25 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1204 | 1204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1205 | 1205 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2424 | 72627-2424-1 | Pyridoxine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-777 | 76154-777-73 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-961 | 70731-961-02 | Niacinamide; Riboflavin 5'-Phosphate Sodium; Dexpanthenol; Thiamine Hydrochloride; Pyridoxine Hydrochloride | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6056 | 71285-6056-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1205 | 1205 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1205 | 1205 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6092 | 71285-6092-1 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-305 | 69374-305-10 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-011 | 73198-011-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1205 | 1205 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1205 | 1205 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1205 | 1205 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0651 | 83863-0651-1 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-440 | 70092-440-76 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1205 | 1205 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0032 | 81483-0032-0 | Sodium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1206 | 1206 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-03 | T-101 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycolic Acid; Hydroquinone; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-779 | 76154-779-75 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nitroglycerin | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mycophenolate Mofetil | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7011 | 71285-7011-1 | Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-321 | 69374-321-25 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-011 | 73198-011-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1206 | 1206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5002 | 26436-5002-1 | Pyridoxine Hydrochloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-1 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7558 | 72934-7558-6 | Salicylic Acid; Ciclopirox Olamine; Clobetasol Propionate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1206 | 1206 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-100 | 83155-100-10 | Sodium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1207 | 1207 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-211 | 73702-211-02 | Fentanyl with 0.2% Ropivacaine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-008 | 71449-008-11 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4834 | 61141-4834-1 | Nitroglycerin | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7036 | 71285-7036-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1207 | 1207 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6007 | 71286-6007-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-022 | 73198-022-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1207 | 1207 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1207 | 1207 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1207 | 1207 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-9 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7556 | 72934-7556-6 | Salicylic Acid; Ketoconazole | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1207 | 1207 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-100 | 83155-100-50 | Sodium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1208 | 1208 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2102 | 72627-2102-3 | Testosterone Cypionate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0740 | 5446-0740-01 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1208 | 1208 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1208 | 1208 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0334 | 60652-0334-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1208 | 1208 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Glutamic Acid; Tyrosine | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6350 | 71266-6350-1 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-325 | 69374-325-25 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-022 | 73198-022-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1208 | 1208 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6858 | 72682-6858-1 | Pyridoxine Hydrochloride; Magnesium Chloride; Dexpanthenol; Calcium Gluconate; Thiamine Hydrochloride; Niacinamide; Cyanocobalamin; Riboflavin | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9005 | 71266-9005-5 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1543 | 72934-1543-2 | Salicylic Acid; Lidocaine | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1208 | 1208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-100 | 83155-100-25 | Sodium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1209 | 1209 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6630 | 71300-6630-2 | Gabapentin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mycophenolate Mofetil | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1209 | 1209 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-686 | 72833-686-02 | Naloxone Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1209 | 1209 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1209 | 1209 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8310 | 71266-8310-1 | Phenylephrine Hydrochloride; Tropicamide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride; Niacinamide; Riboflavin 5'-Phosphate; Dexpanthenol; Thiamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1209 | 1209 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1209 | 1209 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-8552 | 72934-8552-7 | Salicylic Acid; Sulfacetamide Sodium | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1209 | 1209 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-100 | 82396-100-10 | Sodium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1210 | 1210 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-09 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-002 | 70324-002-01 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-0010 | 72682-0010-1 | Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1210 | 1210 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-8552 | 72934-8552-6 | Salicylic Acid; Sulfacetamide Sodium | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1210 | 1210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0204 | 71285-0204-1 | Sodium Chloride; Magnesium Sulfate Heptahydrate; Potassium Chloride; Sodium Bicarbonate; Calcium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1211 | 1211 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-4 | Nolira | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-06 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-476 | 70324-476-01 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-774 | 70004-774-40 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nadide | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6092 | 71285-6092-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-040 | 73198-040-10 | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Polidocanol | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Ascorbic Acid; Magnesium Chloride; Dexpanthenol; Niacinamide; Calcium Gluconate; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1211 | 1211 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-8553 | 72934-8553-6 | Salicylic Acid; Sulfacetamide Sodium | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1211 | 1211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0203 | 71285-0203-1 | Sodium Chloride; Magnesium Sulfate Heptahydrate; Potassium Chloride; Sodium Bicarbonate; Calcium Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1212 | 1212 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-055 | 70713-055-01 | TESTOSTERONE C 200MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-2 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-451 | 70324-451-01 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-775 | 70004-775-40 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-686 | 72833-686-02 | Naloxone Hydrochloride | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1212 | 1212 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1212 | 1212 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7011 | 71285-7011-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-027 | 73198-027-10 | Phentolamine Mesylate; Papaverine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1212 | 1212 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6001 | 26436-6001-1 | Potassium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1212 | 1212 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1212 | 1212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0212 | 71285-0212-1 | Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Lidocaine Hydrochloride; Sodium Bicarbonate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1213 | 1213 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2020 | 70214-2020-1 | Vancomycin 1.25g in 250mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-1 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-1 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-651 | 70324-651-01 | Norepinephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8097 | 71285-8097-1 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5556 | 26436-5556-1 | Naltrexone | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1213 | 1213 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1213 | 1213 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0104 | 60652-0104-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 |